One Care of Southwest Virginia offers

Educational Forum on Prescription Drug Abuse

Abingdon, VA

Agenda

Activity Director:Sarah T. Melton, PharmD, BCPP, BCACP,FASCP

Associate Professor of Pharmacy Practice

Gatton College of Pharmacy at East Tennessee State University

September 24, 2016

Schedule / Topic / Learning Objectives
8:00 AM – 8:30 AM / Breakfast and Registration
8:30 AM – 8:45 AM / Welcome and Introductions
8:45 AM – 9:45 AM / REVIVE! Naloxone Training
Sarah Melton, PharmD /
  • Describe the REVIVE! program, including lay administration of naloxone, protection from civil liability, and the safe reporting of overdoses law.
  • Discuss how opioid overdose emergencies happen and how to recognize them.
  • Describe the mechanism of action of naloxone.
  • Identify risk factors that may make someone more susceptible to an opioid overdose emergency.
  • Respond to an opioid overdose emergency with the administration of naloxone.

9:45 AM – 10:45 AM / Disciplinary Actions from State Regulatory Boards
Hughes Melton, MD /
  • Discuss the reporting requirements for licensees who suspect their colleagues may be improperly prescribing.
  • Describe licensing boards' required approaches to pain management.
  • Explain how to update internal office policies and protocols to avoid disciplinary hearings.

10:45 AM – 11:00 AM / BREAK
11:00 AM – 12:00 PM / Safe Opioid Prescribing
Mary McMasters, MD FASAM
Co-Medical Director, Project REMOTE
Comprehensive Behavioral Health, Fishersville, VA /
  • Define addiction, substance misuse, tolerance, withdrawal, and physical dependence.
  • Understand addiction as a chronic relapsing brain disease.
  • Understand that there is evidence-based medical information on how to treat the disease.
  • Understand how to prescribe opioids as safely as possible.

12:00PM – 1:00PM / Overview of Outpatient Management of Opioid Dependence:Safety and Efficacy ofBuprenorphine and Methadone
Sarah T. Melton, PharmD, BCPP, BCACP,,FASCP
Associate Professor of Pharmacy Practice
Gatton College of Pharmacy at East Tennessee State University / •Explain the rationale and effectiveness of buprenorphine and methadone maintenance therapy in the outpatient treatment of opioid dependence.
•Contrast the safety profiles of buprenorphine and methadone used in the treatment of opiate dependence.
•Describe the components and role of non-pharmacological treatments for opioid dependence.
•Apply clinical tools (e.g., treatment agreements, urine drug screens, pill counts, etc.) needed for an effective outpatient treatment program.
1:00 PM – 1:45 PM / LUNCH
1:45 PM – 2:45 PM / Prescription Monitoring Program (PMP): Your Partner in Patient Management with Controlled Substances
Ralph Orr
Program Director
OR
Carolyn McKann, Deputy Director
Prescription Monitoring Program
Department of Health Professions
Richmond, VA /
  • Review the history of the development, initiation and utilization of the PMP in Virginia.
  • Explain the goals of the PMP.
  • Demonstrate how to use the PMP as a resource in patient-centered care.

2:45 PM – 3:45 PM / Universal Precautions in Prescribing Controlled Substances
Hughes Melton, MD /
  • Describe strategies prescribers and pharmacists can implement to minimize the risk of opioid misuse, abuse, and diversion.
  • Discuss red flags and warning signs of patients who intend to use or distribute opioids for nonmedical purposes.
  • Apply appropriate prescribing of controlled substances in clinical practice based on the CDC Prescribing Guidelines.

3:45 PM – 4:00 PM / Wrap-up and Evaluation